• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN 5.0FR URETHANE UMB CATH; CATHETER, UMBILICAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN 5.0FR URETHANE UMB CATH; CATHETER, UMBILICAL ARTERY Back to Search Results
Model Number 8888160341
Device Problem Fluid/Blood Leak (1250)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 02/06/2019
Event Type  malfunction  
Manufacturer Narrative
The incident sample has been requested but to date has not been received for evaluation.If the sample is received, or if additional information pertinent to the incident is obtained a follow-up report will be submitted.
 
Event Description
The customer reports when they began infusing through a newly inserted umbilical venous catheter, it was noted to have blood backing up in the line and a bubble of fluid leaking at the most proximal edge of the joint where the tubing meets the hub.
 
Manufacturer Narrative
A lot number was not provided therefore a device history record (dhr) review could not be performed.All dhr¿s are reviewed for accuracy prior to releasing the product.A sample consisting of one uvc catheter was returned for evaluation.The catheter showed signs of use; more specifically traces of blood.A visual inspection found that the catheter had a leak below the strain relief junction which may occur during normal use.Manufacturing performs a 100% leak test which would identify this issue during the catheter assembly process.Based on the available information, it can be concluded that product was manufactured according to specifications and the device functioned as intended for an undetermined amount of time; therefore the most probable root cause can be attributed to unintentional damage during use when the user manipulates the device.No trends or triggers have been found, therefore, a corrective or preventive action is not deemed necessary at this time.It must be noted that in-process controls such as personnel training, incoming quality acceptance testing for raw material, 100% in process visual inspection and visual acceptance sampling according to product specification are in place to prevent nonconforming product from leaving the manufacturing operations.This complaint will be used for tracking and trending purposes.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
5.0FR URETHANE UMB CATH
Type of Device
CATHETER, UMBILICAL ARTERY
Manufacturer (Section D)
COVIDIEN
edificio b20 calle #2 zona fra
alajuela
CS 
MDR Report Key8323333
MDR Text Key135693348
Report Number3009211636-2019-00640
Device Sequence Number1
Product Code FOS
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,user f
Type of Report Initial,Followup
Report Date 05/16/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator No Information
Device Model Number8888160341
Device Catalogue Number8888160341
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 02/06/2019
Initial Date FDA Received02/08/2019
Supplement Dates Manufacturer Received02/06/2019
Supplement Dates FDA Received05/16/2019
Patient Sequence Number1
-
-